Özlem Türeci
Fondateur chez BIONTECH SE
Fortune : 79 M $ au 30/04/2024
Postes actifs de Özlem Türeci
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIONTECH SE | Directeur Technique/Scientifique/R&D | 01/01/2018 | - |
| Fondateur | 02/06/2008 | - | |
| Association For Cancer Immunotherapy | President | - | - |
| Directeur/Membre du Conseil | - | - | |
| Ci3 Management UG | Président | - | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - | - |
Historique de carrière de Özlem Türeci
Anciens postes connus de Özlem Türeci
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Directeur Général | 01/01/2008 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2001 | - | |
| Fondateur | 01/01/2001 | - |
Formation de Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Statistiques
Internationale
| Allemagne | 7 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG | |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
- Bourse
- Insiders
- Özlem Türeci
- Expérience
